Investigating the movement of intravitreal human serum albumin nanoparticles in the vitreous and retina

Pharmaceutical Research

Volumn 26, Issue 2, 2009, Pages 329-337

  Kim, Hyuncheol ^a   Robinson, Shaun B ^a   Csaky, Karl G ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Human serum albumin nanoparticles; M ller cells; Trans retinal penetration

Indexed keywords

1,6 HEXANEDIAMINE; COLLAGEN FIBRIL; HUMAN SERUM ALBUMIN; NANOPARTICLE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONFOCAL MICROSCOPY; DRUG PENETRATION; IMMUNOHISTOCHEMISTRY; LASER COAGULATION; MUELLER CELL; NONHUMAN; PRIORITY JOURNAL; RAT; RETINA INJURY; SURFACE CHARGE;

ANIMALS; BRUCH MEMBRANE; CHOROID; DIAMINES; DIFFUSION; DRUG CARRIERS; FLUORESCENT DYES; HUMANS; IMMUNOHISTOCHEMISTRY; LASER THERAPY; MICROSCOPY, CONFOCAL; NANOPARTICLES; PARTICLE SIZE; RATS; RETINA; SERUM ALBUMIN; SURFACE PROPERTIES; VITREOUS BODY;

EID: 58549117281     PISSN: 07248741     EISSN: 1573904X     Source Type: Journal    
DOI: 10.1007/s11095-008-9745-6     Document Type: Article

References (34)

1. S. Duvvuri S. Majumdar A. K. Mitra 2003 Drug delivery to the retina: challenges and opportunities Expert. Opin. Biol. Ther. 3 45 56
2. D. H. Geroski H. F. Edelhauser 2000 Drug delivery for posterior segment eye disease Invest. Ophthalmol. Vis. Sci. 41 961 964
3. J. B. Jonas I. Kreissig A. Sofker R. F. Degenring 2003 Intravitreal injection of triamcinolone for diffuse diabetic macular edema Arch. Ophthalmol. 121 57 61
4. J. I. Lim R. A. Wolitz A. H. Dowling H. R. Bloom A. R. Irvine D. M. Schwartz 1999 Visual and anatomic outcomes associated with posterior segment complications after ganciclovir implant procedures in patients with AIDS and cytomegalovirus retinitis Am. J. Ophthalmol. 127 288 293
5. T. S. Shane D. F. Martin 2003 Endophthalmitis after ganciclovir implant in patients with AIDS and cytomegalovirus retinitis Am. J. Ophthalmol. 136 649 654
6. S. K. Sahoo F. Dilnawaz S. Krishnakumar 2008 Nanotechnology in ocular drug delivery Drug Discov. Today 13 144 151
7. J. M. Irache M. Merodio A. Arnedo M. A. Camapanero M. Mirshahi S. Espuelas 2005 Albumin nanoparticles for the intravitreal delivery of anticytomegaloviral drugs Mini. Rev. Med. Chem. 5 293 305
8. Y. Mo M. E. Barnett D. Takemoto H. Davidson U. B. Kompella 2007 Human serum albumin nanoparticles for efficient delivery of Cu, Zn superoxide dismutase gene Mol. Vis. 13 746 757
9. S. Segura S. Espuelas M. J. Renedo J. M. Irache 2005 Potential of albumin nanoparticles as carriers for interferon gamma Drug Dev. Ind. Pharm. 31 271 280
10. C. Weber J. Kreuter K. Langer 2000 Desolvation process and surface characteristics of HSA-nanoparticles Int. J. Pharm. 196 197 200
11. D. Fischer T. Bieber S. Brusselbach H. Elsasser T. Kissel 2001 Cationized human serum albumin as a non-viral vector system for gene delivery? Characterization of complex formation with plasmid DNA and transfection efficiency Int. J. Pharm. 225 97 111
12. M. Sehested K. Hou-Jensen 1981 Factor VII related antigen as an endothelial cell marker in benign and malignant diseases Virchows. Arch. A. Pathol. Anat. Histol. 391 217 225
13. H. Chen A. J. Weber 2002 Expression of glial fibrillary acidic protein and glutamine synthetase by Muller cells after optic nerve damage and intravitreal application of brain-derived neurotrophic factor Glia. 38 115 125
14. R. A. Bejjani D. BenEzra H. Cohen J. Rieger C. Andrieu J. C. Jeanny G. Gollomb F. F. Behar-Cohen 2005 Nanoparticles for gene delivery to retinal pigment epithelial cells Mol. Vis. 11 124 132
15. J. L. Bourges S. E. Gautier F. Delie R. A. Bejjani J. C. Jeanny R. Gurny D. BenEzra F. F. Behar-Cohen 2003 Ocular drug delivery targeting the retina and retinal pigment epithelium using polylactide nanoparticles Invest. Ophthalmol. Vis. Sci. 44 3562 3569
16. Y. de Kozak K. Andrieux H. Villarroya C. Klein B. Thillaye-Goldenberg M. C. Naud E. Garcia P. Couvreur 2004 Intraocular injection of tamoxifen-loaded nanoparticles: a new treatment of experimental autoimmune uveoretinitis Eur. J. Immunol. 34 3702 3712
17. L. I. Los M. J. van Luyn P. Nieuwenhuis 1999 Organization of the rabbit vitreous body: lamellae, Cloquet's channel and a novel structure, the 'alae canalis Cloqueti' Exp. Eye. Res. 69 343 350
18. E. Sakurai H. Ozeki N. Kunou Y. Ogura 2001 Effect of particle size of polymeric nanospheres on intravitreal kinetics Ophthalmic. Res. 33 31 36
19. L. Pitkanen M. Ruponen J. Nieminen A. Urtti 2003 Vitreous is a barrier in nonviral gene transfer by cationic lipids and polymers Pharm. Res. 20 576 583
20. M. Ruponen S. Yla-Herttuala A. Urtti 1999 Interactions of polymeric and liposomal gene delivery systems with extracellular glycosaminoglycans: physicochemical and transfection studies Biochim. Biophys. Acta 1415 331 341
21. L. Peeters N. N. Sanders K. Braeckmans K. Boussery J. Van de Voorde S. C. De Smedt J. Demeester 2005 Vitreous: a barrier to nonviral ocular gene therapy Invest. Ophthalmol. Vis. Sci. 46 3553 3561
22. W. Lu Y. Zhang Y. Z. Tan K. L. Hu X. G. Jiang S. K. Fu 2005 Cationic albumin-conjugated pegylated nanoparticles as novel drug carrier for brain delivery J. Control. Release 107 428 448
23. S. R. Russell J. D. Shepherd G. S. Hageman 1991 Distribution of glycoconjugates in the human retinal internal limiting membrane Invest. Ophthalmol. Vis. Sci. 32 1986 1995
24. H. Nishihara 1991 Studies on the ultrastructure of the inner limiting membrane of the retina-distribution of anionic sites in the inner limiting membrane of the retina Nippon. Ganka. Gakkai. Zasshi. 95 951 958
25. M. Kamei K. Misono H. Lewis 1999 A study of the ability of tissue plasminogen activator to diffuse into the subretinal space after intravitreal injection in rabbits Am. J. Ophthalmol. 128 739 746
26. L. Chai J. E. Morris 1994 Distribution of heparan sulfate proteoglycans in embryonic chicken neural retina and isolated inner limiting membrane Curr. Eye Res. 13 669 677
27. S. Heegaard O. A. Jensen J. U. Prause 1986 Structure and composition of the inner limiting membrane of the retina. SEM on frozen resin-cracked and enzyme-digested retinas of Macaca mulatta Graefes. Arch. Clin. Exp. Ophthalmol. 224 355 360
28. T. L. Jackson R. J. Antcliff J. Hillenkamp J. Marshall 2003 Human retinal molecular weight exclusion limit and estimate of species variation Invest. Ophthalmol. Vis. Sci. 44 2141 2146
29. A. H. Bunt-Milam J. C. Saari I. B. Klock G. G. Garwin 1985 Zonulae adherents pore size in the external limiting membrane of the rabbit retina Invest. Ophthalmol. Vis. Sci. 26 1377 1380
30. M. J. Alonso 2004 Nanomedicines for overcoming biological barriers Biomed. Pharmacother. 58 168 172
31. J. Kreuter 2001 Nanoparticulate systems for brain delivery of drugs Adv. Drug Deliv. Rev. 47 65 81
32. N. Normand F. Valamanesh M. Savoldelli F. Mascarelli D. BenEzra Y. Courtois F. Behar-Cohen 2005 VP22 light controlled delivery of oligonucleotides to ocular cells in vitro and in vivo Mol. Vis. 11 184 191
33. T. Fukuchi K. Takahashi K. Shou M. Matsumura 2001 Optical coherence tomography (OCT) findings in normal retina and laser-induced choroidal neovascularization in rats Graefes Arch Clin. Exp. Ophthalmol. 239 41 46
34. R. J. Marano I. Toth N. Wimmer M. Brankov P. E. Rakoczy 2005 Dendrimer delivery of an anti-VEGF oligonucleotide into the eye: a long-term study into inhibition of laser-induced CNV, distribution, uptake and toxicity Gene. Ther. 12 1544 1550